Advanced Biomed Inc. Common Stock
ADVB | NASDAQ
$6.81
+$0.34 (+5.26%)
Sep 22, 2026, 10:43 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Jun 29, 2025 | FY 2024 Jun 29, 2024 | FY 2023 Jun 29, 2023 | FY 2022 Jun 29, 2022 | FY 2021 Jun 29, 2021 |
|---|---|---|---|---|---|
Net Income | -101.52K | -2.78M | -3.73M | -4.03M | -1.84M |
Depreciation & Amortization | 10.71K | 399.6K | 365.23K | 126.63K | 57.85K |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -86.99K | -276.79K | -148.94K | 591.37K | 1.29M |
Other Non-Cash Items | n/a | n/a | 150.21K | 1.66M | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -90.65K | 256.34K | 253.71K | 1.5M | 1.31M |
Operating Cash Flow | -181.46K | -2.13M | -2.96M | -741.45K | -473.98K |
Capital Expenditures | -985 | -74.11K | -212.52K | -1.31M | -25.44K |
Cash Acquisitions | n/a | n/a | -50.49K | 199.53K | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -1.64K | -393.62K | n/a |
Investing Cash Flow | -985 | -74.11K | -263.01K | -1.08M | -25.44K |
Debt Repayment | 13.72K | 1.66M | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 0.41 | 212.18K | -553.47K | n/a | n/a |
Financial Cash Flow | 184.87K | 1.87M | 458.14K | 6.1M | 697.16K |
Net Cash Flow | 19.02K | -14.31K | -2.16M | 4.72M | 217 |
Free Cash Flow | -182.45K | -2.2M | -3.18M | -2.05M | -499.42K |
Adj. Free Cash Flow | -182.45K | -2.2M | -3.18M | -2.05M | -499.42K |
Maintenance CapEx | -985 | -74.11K | -212.52K | -126.63K | -25.44K |
Growth CapEx | n/a | n/a | n/a | -1.19M | n/a |
Owner Earnings | -182.45K | -2.2M | -3.18M | -868.08K | -499.42K |
Add to Watchlist
Select watchlists to add or remove ADVB